Not only that, PPH@CR may also reactivate the body’s anti-tumor immune response by inducing ICD and reducing the expression of PD-L1 in tumor cells, as well as help reduce tumor recurrence and treatment resistance by reducing cancer stem cells. This evidence concerns the gene CD274 and neoplasm.